Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups

Courtney M. Rowan, Francis Pike, Kenneth R. Cooke, Robert Krance, Paul A. Carpenter, Christine Duncan, David A. Jacobsohn, Catherine M. Bollard, Conrad Russell Y. Cruz, Abhijeet Malatpure, Sherif S. Farag, Jamie Renbarger, Hao Liu, Giorgos Bakoyannis, Samir Hanash, Sophie Paczesny

Blood (2020) 135 (17): 1428–1437.

https://doi.org/10.1182/blood.2019002334

Published: 2020

Includes: Supplemental data

Journal Articles

ST2 and Rg3a As a Biomarker for Predicting of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Hakan Goker, MDPROF., Elifcan Aladag, MD, Yahya Buyukasik, MD, Nelson J. Chao, MD, Umit Akman, Bio., Haluk Demiroglu, MDPROF.

Blood (2019) 134 (Supplement_1): 5684.

https://doi.org/10.1182/blood-2019-121682

Published: 2019

Journal Articles

Predictive Values of Early ST2 for Acute Graft-Versus-Host Disease and Transplant-Related Complications after Allogeneic Stem Cell Transplantation

Takuya Miyazaki, Ayako Matsumura, MD, Takayoshi Tachibana, Taiki Ando, MD, Megumi Koyama, MD, Satoshi Koyama, MD, Yoshimi Ishii, MD, Hiroyuki Takahashi, MD, Yuki Nakajima, MD, Ayumi Numata, MD, Wataru Yamamoto, MD, Kenji Motohashi, MD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD, Shin Fujisawa, MD, Hideaki Nakajima, MD

Blood (2019) 134 (Supplement_1): 1976.

https://doi.org/10.1182/blood-2019-123262

Published: 2019

Journal Articles

Low Levels of Plasmacytoid Dendritic Cells at the Time of Engraftment Are a Valuable Severe aGVHD Indicator in Children Undergoing Allogeneic Stem Cell Transplantation

Bohan Li, Xinran Chu, Lijun Meng, PhD, Peifang Xiao, MD, Jie Li, MD, Jun Lu, MD, Yi Zhang, MD PhD, Shaoyan Hu, MD PhD

Blood (2019) 134 (Supplement_1): 3288.

https://doi.org/10.1182/blood-2019-128191

Published: 2019

Journal Articles

Uncovering the Molecular Signature of Pathogenic Tissue-Infiltrating T Cells during Acute Graft-Versus-Host Disease

Victor Tkachev, PhD, Scott N Furlan, MD, E. Lake Potter, Hengqi Zheng, MD, Daniel J Hunt, Lucrezia Colonna, PhD, Agne Taraseviciute, MD PhD, Judith M Carlson, BS, Kayla Betz, Alison Yu, PhD, Michelle Hoffman, MS, Audrey Baldessari, DVM, Sarah Herrin, Joe Olvera, Chad Littlewood, Christopher English, Bruce R. Blazar, MD, Mario Roederer, PhD, Leslie Kean, MD PhD

Blood (2018) 132 (Supplement 1): 805.

https://doi.org/10.1182/blood-2018-99-113652

Published: 2018

Journal Articles

ST2 and ROR-γ-t Roles in Intestinal Regulatory T Cells

Jinfeng Yang, PhD, Abdulraouf Ramadan, PhD, Dawn Reichenbach, PhD, Michael Loschi, MD, Jilu Zhang, PhD, Brad Griesenauer, PhD, Hong Liu, MS, Keli Lee Hippen, PhD, Bruce R. Blazar, MD, Sophie Paczesny, MD PhD

Blood (2018) 132 (Supplement 1): 66.

https://doi.org/10.1182/blood-2018-99-113003

Published: 2018

Journal Articles

Multiple Functional Donor Polymorphisms in IL1RL1 region Associate with Death Due to GvHD or Infection after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for AML and MDS

Blood (2018) 132 (Supplement 1): 312.

https://doi.org/10.1182/blood-2018-99-115276

Published: 2018

Journal Articles

ST2 As a Biomarker of Non-Relapse Mortality after HLA-Haploidentical SCT with High-Dose Post-Transplantation Cyclophosphamide

Laura Solán, PhD, Carolina Martínez-Laperche, PhD, Mi Kwon, Diego Carbonell, Pascual Balsalobre, David Serrano, María Chicano, PhD, Julia Suárez-González, Javier Anguita, MD PhD, Jorge Gayoso, MD, Ismael Buño, Jose L. Diez-Martin, MD PhD

Blood (2017) 130 (Supplement 1): 3313.

https://doi.org/10.1182/blood.V130.Suppl_1.3313.3313

Published: 2017

Journal Articles

Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post–allogeneic HCT

Mohammad Abu Zaid, Juan Wu, Cindy Wu, Brent R. Logan, Jeffrey Yu, Corey Cutler, Joseph H. Antin, Sophie Paczesny, Sung Won Choi

Blood (2017) 129 (2): 162–170.

https://doi.org/10.1182/blood-2016-08-735324

Published: 2017

Includes: Supplemental data

Journal Articles

It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)

Thomas Luft, MD PhD, Axel Benner, Sonata Jodele, MD, Christopher E. Dandoy, MD, Rainer F. Storb, MD, Ted A. Gooley, PhD, Brenda M. Sandmaier, MD, Aleksandar Radujkovic, MD, Anthony D. Ho, MD, Peter Dreger, MD, Olaf Penack, MD

Blood (2016) 128 (22): 519.

https://doi.org/10.1182/blood.V128.22.519.519

Published: 2016

Journal Articles

Small Molecule ST2 Inhibitors Cause Reduction of Soluble ST2 and Improve Gvhd and Survival In Vivo

Chao-Yie Yang, PhD, Abdulraouf Ramadan, PhD, Etienne Daguindau, MD, Jilu Zhang, PhD, Zachary Bolten, Krishnapriya Chinnaswamy, MS, Jeanne Stuckey, PhD, Sophie Paczesny, MD PhD

Blood (2016) 128 (22): 528.

https://doi.org/10.1182/blood.V128.22.528.528

Published: 2016

Journal Articles

Notch1-Activated B Cells Have an Immunomodulatory Function Enhancing Th2 and Treg Immune Response Via IL-33-ST2 Pathway

Hiroshi Arima, MD, Momoko Nishikori, MD PhD, Yasuyuki Otsuka, MD, Kiyotaka Izumi, MD, Wataru Kishimoto, MD, Akifumi Takaori-Kondo, MD PhD

Blood (2016) 128 (22): 130.

https://doi.org/10.1182/blood.V128.22.130.130

Published: 2016

Journal Articles

Reichenbach DK, Schwarze V, Matta BM, et al. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD. Blood. 2015;125(20): 3183-3192 .

Blood (2016) 128 (9): 1311.

https://doi.org/10.1182/blood-2016-07-728048

Published: 2016

Journal Articles

Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD

Benjamin M. Matta, Dawn K. Reichenbach, Xiaoli Zhang, Lisa Mathews, Brent H. Koehn, Gaelen K. Dwyer, Jeremy M. Lott, Franziska M. Uhl, Dietmar Pfeifer, Colby J. Feser, Michelle J. Smith, Quan Liu, Robert Zeiser, Bruce R. Blazar, Hēth R. Turnquist

Blood (2016) 128 (3): 427–439.

https://doi.org/10.1182/blood-2015-12-684142

Published: 2016

Includes: Supplemental data

Journal Articles

ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice

Julia E. Rood, Sheila Rao, Michele Paessler, Portia A. Kreiger, Niansheng Chu, Erietta Stelekati, E. John Wherry, Edward M. Behrens

Blood (2016) 127 (4): 426–435.

https://doi.org/10.1182/blood-2015-07-659813

Published: 2016

Includes: Supplemental data

Journal Articles

GATA2 Expression Level in Chronic Myeloid Leukemia (CML) Patients Correlates with Their Prognostic Scores and Is Associated with Disease Stage at Diagnosis

Philippe Guardiola, MD, Corentin Orvain, Nick C.P. Cross, PhD, Martine Gardembas, MD, Marc Spentchian, MD, Estelle Pedrono, PhD, Diane Lambert, PhD, Anne Coutolleau, Anne Bouvier, MD, Odile Blanchet, MDPhD, Nicole Piard, MD, Norbert Ifrah, MD PhD, Frank Giles, MD MB, FRCPI, FRCPath, Andreas Hochhaus, MD, Jerald P. Radich, MD, Philippe Rousselot, MD PhD

Blood (2015) 126 (23): 2768.

https://doi.org/10.1182/blood.V126.23.2768.2768

Published: 2015

Journal Articles

IL-33/ST2 Triggering of IL-9-Secreting T Cells Alters the Balance of Fatal Immunity and Tumor Immunity

Abdulraouf Ramadan, PhD, Jilu Zhang, PhD, Mohammad Abu Zaid, MD, Heather O'Leary, PhD, Reuben Kapur, PhD, Helmut Hanenberg, MD, Jie Sun, PhD, Hal E. Broxmeyer, PhD, Mark H. Kaplan, PhD, Sophie Paczesny, MD PhD

Blood (2015) 126 (23): 231.

https://doi.org/10.1182/blood.V126.23.231.231

Published: 2015

Journal Articles

The IL-33/ST2 axis augments effector T-cell responses during acute GVHD

Blood (2015) 125 (20): 3183–3192.

https://doi.org/10.1182/blood-2014-10-606830

Published: 2015

Includes: Supplemental data

Journal Articles

ST2: the biomarker at the heart of GVHD severity

Sawa Ito, A. John Barrett

Blood (2015) 125 (1): 10–11.

https://doi.org/10.1182/blood-2014-11-611780

Published: 2015

Journal Articles

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation

Blood (2015) 125 (1): 199–205.

https://doi.org/10.1182/blood-2014-06-584789

Published: 2015

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups

ST2 and Rg3a As a Biomarker for Predicting of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Predictive Values of Early ST2 for Acute Graft-Versus-Host Disease and Transplant-Related Complications after Allogeneic Stem Cell Transplantation

Low Levels of Plasmacytoid Dendritic Cells at the Time of Engraftment Are a Valuable Severe aGVHD Indicator in Children Undergoing Allogeneic Stem Cell Transplantation

Uncovering the Molecular Signature of Pathogenic Tissue-Infiltrating T Cells during Acute Graft-Versus-Host Disease

ST2 and ROR-γ-t Roles in Intestinal Regulatory T Cells

Multiple Functional Donor Polymorphisms in IL1RL1 region Associate with Death Due to GvHD or Infection after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for AML and MDS

ST2 As a Biomarker of Non-Relapse Mortality after HLA-Haploidentical SCT with High-Dose Post-Transplantation Cyclophosphamide

Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post–allogeneic HCT

It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)

Small Molecule ST2 Inhibitors Cause Reduction of Soluble ST2 and Improve Gvhd and Survival In Vivo

Notch1-Activated B Cells Have an Immunomodulatory Function Enhancing Th2 and Treg Immune Response Via IL-33-ST2 Pathway

Reichenbach DK, Schwarze V, Matta BM, et al. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD. Blood. 2015;125(20): 3183-3192 .

Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD

ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice

GATA2 Expression Level in Chronic Myeloid Leukemia (CML) Patients Correlates with Their Prognostic Scores and Is Associated with Disease Stage at Diagnosis

IL-33/ST2 Triggering of IL-9-Secreting T Cells Alters the Balance of Fatal Immunity and Tumor Immunity

The IL-33/ST2 axis augments effector T-cell responses during acute GVHD

ST2: the biomarker at the heart of GVHD severity

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only